Welcome to DZIF
It is the 21st century and infections are still a major challenge for medicine. What is our recourse as germs become increasingly resistant to antibiotics? What can we do to prevent the spread of a pathogen? The researchers at the German Center for Infection Research (DZIF) are tackling these and many other issues.
DZIF scientist in the Ebola crisis region
DZIF infectious disease and tropical medicine specialist Günter Fröschl, from Munich, spent two months in Liberia, to help with the largest Ebola epidemic seen to date. We spoke to him about his work in the crisis region.
Researchers discover novel antibiotic agent
DZIF-Scientist Dr Tanja Schneider and her group at the University of Bonn participated in a hopeful discovery: Teixobactin is the name of a new antibiotic compound which is effective against a broad spectrum of pathogens. Photo: University of Bonn
Tuberculosis: Multidrug resistance is a major challenge
DZIF Professor Stefan Niemann, Forschungszentrum Borstel, explains which problems need to be solved in optimising new drugs against tuberculosis.
The European Congress of Clinical Microbiology and Infectious Diseases will take place 25 to 28 April 2015 in Copenhagen, Denmark. The DZIF will be present.
DZIF e.V. – Inhoffenstraße 7, 38124 Braunschweig, Germany
PHONE +49 531-6181 1152 EMAIL firstname.lastname@example.org